The Deadly Diseases in Africa Programme Phase II (TDDAP2) will implement the UK and Africa’s vision for global progress on health security, building on African successes from the COVID-19 pandemic and other outbreaks’ responses.
With some of the world’s most fragile ecosystems and least developed health systems, Africa is home to 22 of the world’s 25 countries most susceptible to infection disease outbreaks. This vulnerability poses significant risks to both regional and global health.
Global health security (GHS) support programmes, led by organisations such as the FCDO (UK’s Foreign, Commonwealth & Development Office) and USAID (U.S. Agency for International Development), are crucial for strengthening health systems, improving disease surveillance, and enabling rapid response to outbreaks.
Funded by the UK Foreign, Commonwealth and Development Office, TDDAP2 builds on its first iteration to address critical junctures in the continuum of pandemic preparedness, prevention and response across the African region.
Our role
We are delivering the monitoring, evaluation and learning requirements of the TDDAP2 programme to maximise the programme’s economy, effectiveness, efficiency, equity and sustainability of impact after the programme ends.
Additionally, we will build the evidence base on regional responses to cross-border health threats and test linkages and assumptions within the TDDAP2 Theory of Change to inform adjustments. This will provide FCDO, and other UK government departments, with new, quality evidence on what does and doesn’t work for building national capacity to prevent, detect and respond to disease outbreaks.
We are leading the TDDAP2 MEL contract in partnership with Tropical Health, the Infectious Diseases Institute (IDI), and Kinshasa School of Public Health (KSPH), DRC.
We will conduct:
- Monitoring and results verification to ensure ongoing, systematic quality collection of data from all TDDAP2 components.
- Endline Evaluation to assess TDDAP2’s performance and overall impacts against the Theory of Change.
- Evidence Dissemination and Learning to analyse, synthesise and present information generated from monitoring and evaluations (and from any other evidence-generating activities undertaken by Implementing Partners) and use it to continuously improve the programme’s ability to achieve results.
Our methods & approaches
Our technical approach is designed around TDDAP2’s Theory of Change, with three interlinked and flexible MEL components that connect independent monitoring and verification, robust evaluation, and reflexive learning through a shared approach to MEL processes, systems and data flow.
Our overall approach will be informed by key principles of being agile, impartial, participatory and utilisation-focused.
We are providing support under three core workstreams:
1. Monitoring and results verification
We will provide FCDO with assurance regarding the reliability and accuracy of reported data, while also fostering a deeper understanding of context by verifying and exploring reported outcomes, including VfM.
Our MEL technical assistance work will also support the maintenance of high-quality implementation MEL systems. In this way, we will ensure accountability among implementers for the results they report and enhance understanding of programme implementation to inform learning, including identification of any risks.
2. Evaluation
We will conduct a progress review and an endline evaluation of the TDDAP2 programme. We will use the TDDAP2 Theory of Change to guide our theory-based approach which will generate evidence to inform adaptation and generate key insights on what works in Global Health Security.
3. Learning & Dissemination
This workstream is central to our overall delivery strategy, where evidence generated through the other two workstreams will be managed and used for dissemination and course correction.
Cornerstones of our approach will be a learning agenda based on available evidence from our workstreams and brokered through an annual learning workshop and sensemaking activities, and the production of tailored special studies and knowledge products. Evidence from our work will be curated in a dedicated Knowledge Hub, a platform which will support the dissemination of evidence internally to enable course correction by implementing partners to strengthen programme delivery, and externally to contribute to learning of what works and why within the wider GHS sector.
Outcomes
Through our support, we will improve the overall performance of TDDAP2 and more effective coordination of its components to deliver the programme’s desired overall outcomes and generate sustainability.
Within this, we aim to ensure that:
- TDDAP2’s results and VfM are verified on an ongoing sample basis
- TDDAP2’s progress toward its intended outputs and outcomes is successfully tracked and reported to ensure accountability
- Learning is applied to TDDAP2’s delivery and management — both at the component and overall programme levels — to ensure the overall objectives of the programme are met, risks to delivery assessed, and opportunities are maximised for overall efficiency and effectiveness
- Learning products are produced and where relevant disseminated, documenting successful and unsuccessful outcomes of TDDAP2 components
- New, quality evidence is produced to strengthen the evidence base on what works and what does not work for an effective regional response to cross-border health threats, as well as building national capacity to prevent, detect and respond to disease outbreaks
